...
首页> 外文期刊>Redox Biology >New potential biomarker for stratification of patients for pharmacological vitamin C in adjuvant settings of cancer therapy
【24h】

New potential biomarker for stratification of patients for pharmacological vitamin C in adjuvant settings of cancer therapy

机译:新潜在的生物标志物,用于癌症治疗辅助环境中药理学维生素C患者的分层

获取原文
           

摘要

Our graphical review expands the analysis of cancer vulnerabilities for high dose vitamin C, based on several facts, illustrating the cytotoxic potential of the ascorbate free radical (AFR) via impairment of mitochondrial respiration and the mechanisms of its elimination in mammals by the membrane-bound NADH:cytochrome b5 oxidoreductase 3 (Cyb5R3). We propose that vitamin C can function in “protective mode” or “destructive mode” affecting cellular homeostasis, depending on the intracellular “steady-state” concentration of AFR and differential expression/activity of Cyb5R3 in cancerous and normal cells. Thus, a specific anti-cancer effect can be achieved at high doses of vitamin C therapy. The review is intended for a wide audience of readers – from students to specialists in the field.
机译:我们的图形评论扩大了基于几个事实的高剂量维生素C对高剂量维生素C的癌症脆弱性分析,所述若干事实,通过线粒体呼吸的损伤和通过膜结合的哺乳动物中的消除机制的抗坏血酸自由基(AFR)的细胞毒性潜力NADH:细胞色素B5氧化还原酶3(CYB5R3)。我们提出维生素C可以在“保护模式”或“破坏模式”中起作用影响细胞稳态,这取决于细胞内的“稳态”浓度的AFR和CYB5R3在癌性和正常细胞中的差异表达/活性。因此,可以在高剂量的维生素C治疗中实现特异性抗癌作用。审查适用于读者的广泛观众 - 从学生到该领域的专家。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号